KLKhrystyna Lishchuk-Yakymovych

Khrystyna Lishchuk-Yakymovych

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khrystyna Lishchuk-Yakymovych has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 18 November 2026
    • Published by MDPI AG in Preprints.org
      • https://doi.org/10.20944/preprints202611.1784.v1
    Open Access

    Analysis of Nasal Lavage Fluid in the Differential Diagnosis of Local Allergic Rhinitis

    by Edyta Krzych-Fałta, Sławomir Białek, Khrystyna Lishchuk-Yakymovych

    Allergic rhinitis (AR) is the most common chronic inflammatory disease of the upper airways and has traditionally been classified as an IgE-mediated inflammatory disorder of the nasal mucosa. However, accumulating evidence indicates that AR is a complex immune-mediated disease associated with type 2 inflammation, driven by interactions among genetic predisposition, environmental exposures, epithelial barrier dysfunction, and impaired immune regulation. Disruption of epithelial integrity promotes the release of alarmins, which initiate innate immune activation and subsequently amplify the adaptive type 2 immune response. Sustained production of IL-4, IL-5, and IL-13 contributes to IgE synthesis, eosinophilic inflammation, and chronic remodeling of the nasal mucosa. Within this immunological framework, local allergic rhinitis (LAR) has emerged as a distinct disease endotype, despite negative results on conventional allergy tests. Concurrently, advances in diagnostic methodologies, including molecular allergy diagnostics, nasal allergen provocation testing, and the assessment of allergen-specific IgE and allergic inflammatory mediators in samples collected directly from the nasal cavity, have enabled the evaluation of immune responses at the target organ level. Increasing emphasis is also being placed on precision medicine based on inflammatory endotypes and treatable traits. The development of biologic therapies targeting IgE, IL-4/IL-13, IL-5, and epithelial-derived cytokines exemplifies the transition from symptom-oriented treatment towards mechanism-based therapeutic strategies. Further integration of molecular diagnostics with targeted immunomodulation is expected to improve disease control and facilitate more individualized management of patients with allergic rhinitis and local allergic rhinitis.

  • Open Access

    Personalized Data Analysis Approach for Assessing Necessary Hospital Bed-Days Built on Condition Space and Hierarchical Predictor

    by Nataliia Melnykova, Nataliya Shakhovska, Volodymyr Melnykov, Kateryna Melnykova, Khrystyna Lishchuk-Yakymovych

    The paper describes the medical data personalization problem by determining the individual characteristics needed to predict the number of days a patient spends in a hospital. The mathematical problem of patient information analysis is formalized, which will help identify critical personal characteristics based on conditioned space analysis. The condition space is given in cube form as a reflection of the functional relationship of the general parameters to the studied object. The dataset consists of 51 instances, and ten parameters are processed using different clustering and regression models. Days in hospital is the target variable. A condition space cube is formed based on clustering analysis and features selection. In this manner, a hierarchical predictor based on clustering and an ensemble of weak regressors is built. The quality of the developed hierarchical predictor for Root Mean Squared Error metric is 1.47 times better than the best weak predictor (perceptron with 12 units in a single hidden layer).